Article
Human expandable pancreatic progenitor–derived β cells ameliorate diabetes
23 Feb 2022
Abstract excerpt
An unlimited source of human pancreatic β cells is in high demand. Even with recent advances in pancreatic differentiation from human pluripotent stem cells, major hurdles remain in large-scale and cost-effective production of functional β cells. Here, through chemical screening, we demonstrate that the bromodomain and extraterminal domain (BET) inhibitor I-BET151 can robustly promote the expansion of PDX1 +...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
